COMPASS Pathways plc (CMPS)
NASDAQ: CMPS · Real-Time Price · USD
4.140
+0.110 (2.73%)
Dec 26, 2024, 4:00 PM EST - Market closed
COMPASS Pathways Market Cap
COMPASS Pathways has a market cap or net worth of $283.26 million as of December 27, 2024. Its market cap has decreased by -34.06% in one year.
Market Cap
283.26M
Enterprise Value
108.86M
1-Year Change
-34.06%
Ranking
Category
Stock Price
$4.14
Market Cap Chart
Since the IPO on September 18, 2020, COMPASS Pathways's market cap has decreased from $568.58M to $283.26M, a decrease of -50.18%. That is a compound annual growth rate of -15.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2024 | 275.74M | -49.09% |
| Dec 29, 2023 | 541.59M | 58.41% |
| Dec 30, 2022 | 341.89M | -62.93% |
| Dec 31, 2021 | 922.26M | -46.12% |
| Dec 31, 2020 | 1.71B | 201.05% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aldeyra Therapeutics | 283.16M |
| Vanda Pharmaceuticals | 281.63M |
| Lifecore Biomedical | 279.89M |
| Procaps Group | 279.80M |
| Foghorn Therapeutics | 279.08M |
| ProQR Therapeutics | 275.55M |
| OraSure Technologies | 275.25M |
| Atea Pharmaceuticals | 274.50M |